Routine monitoring considerations: For most patients on GLP-1 therapy, routine magnesium level testing is not necessary
Despite the appearance of endless products and brands, as the VMS market grows, private label is responsible for a large portion of the footprint, though it is very fragmented
Dirr H, Reinemer P, Huber R
The product itself does not automatically require medical authorization
At The FDA Group, our teams conduct: Mock FDA inspections (including CDER focus areas) Whether you need a onetime gap assessment, routine coverage, or additional bandwidth to protect timelines, we bring former FDA investigators and experienced industry auditors directly into your process, without adding permanent headcount